Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06015438 · ClinicalTrials.gov registry record · NA

Physical Activity in Hidradenitis Suppurativa (HS)

A NA study of Hidradenitis Suppurativa, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06015438 is a NA study of Hidradenitis Suppurativa that is actively recruiting participants, run by University of Miami. The registered enrollment target is 50 participants, below the 597-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06015438, a NA study of Hidradenitis Suppurativa, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to characterize the challenges to physical activity and exercise for HS patients and design an exercise program (EP) with evidence-based techniques and examine its outcome.

Conditions Studied

Interventions

  • BEHAVIORAL Home Exercise Program
  • BEHAVIORAL Short Exercise Program

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-06-07
Est. Completion 2026-05-01
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06015438

The ClinicalTrials.gov registry entry for NCT06015438 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 597-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (92% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 2 interventions - of which Home Exercise Program is the first listed.

NCT06015438 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06015438 about?

NCT06015438 is a clinical study titled "Physical Activity in Hidradenitis Suppurativa (HS)". The purpose of the study is to characterize the challenges to physical activity and exercise for HS patients and design an exercise program (EP) with evidence-based techniques and examine its outcome.

What is the current status of trial NCT06015438?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-06-07. Estimated completion is 2026-05-01.

What conditions does trial NCT06015438 study?

This clinical trial studies the following conditions: Hidradenitis Suppurativa.

What interventions are being tested in trial NCT06015438?

The interventions under investigation include: Home Exercise Program (BEHAVIORAL), Short Exercise Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06015438?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06015438 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hidradenitis Suppurativa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.